Intended for scientific audiences only.
BMS at ASCO 2020
Pursuing diverse scientific approaches with the potential to improve outcomes for patients with cancer at the virtual American Society of Clinical Oncology Annual Meeting, May 29-31
While this year’s ASCO falls during an unparalleled time, we look forward to joining the oncology community virtually and sharing findings across a wide range of cancers and research platforms. At Bristol Myers Squibb, we are inspired to do our part by the healthcare professionals on the frontlines, and we are reminded of the strength there is in science.
A Message from Our CEO
Working together, we will deliver on our promise of transforming patients’ lives through science.
Daily Updates from ASCO 2020
Find out what you need to know each day about our ASCO 2020 data presentations.
Data in Focus, Day 3: Lung Cancer & Melanoma
Data in Focus, Day 2: Hematology
Data in Focus, Day 1: Cell Therapy
Learn About Our Science
Every day, we focus on advancing science to better support oncology patients and doctors. Learn about our ongoing developments and scientific heritage in oncology:
The needs of patients with lung cancer are unique, which is why we’re exploring a variety of treatment approaches. Learn more from BMS’ thoracic cancers development lead, Sabine Maier, M.D.
Supporting the Oncology Community Before, During and After COVID-19
We are inspired to do our part by oncologists and the entire medical community because of the work they do each day during these difficult times.
Explore stats and facts about the areas of oncology and hematology where we are presenting new research during ASCO: